Current Liabilities Endring Dato
AbbVie USD 34.77B 2.53B 2023-09
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
Astellas Pharma JPY 1.16T 170.76B 2023-09
AstraZeneca USD 28.59B 2.21B 2023-09
Bayer EUR 33.08B 894M 2023-09
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Daiichi Sankyo JPY 532.25B 19.14B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Roche Holding CHF 26.21B 1.03B 2023-06
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Agios Pharmaceuticals Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.